DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock Aug 14, 2026 05:25PM
DataMeds AI unit reports $600K monthly revenue and new GLP-1 drugs Aug 12, 2026 07:40AM
DataMeds AI Provides Update on Corexa Health's Pharmacy Division Aug 12, 2026 07:40AM
DataMeds AI renames pharmacy units under new Corexa Health division Aug 10, 2026 08:31AM
DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division Aug 10, 2026 08:30AM


Aug 6, 2026 08:15AM DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date
Aug 5, 2026 08:30AM DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"
Jul 31, 2026 08:30AM DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)
Jul 29, 2026 10:17AM DataMeds AI and Datavault AI expand healthcare data licensing deal
Jul 29, 2026 10:15AM DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License
Jul 29, 2026 09:06AM Datavault AI amends DataMeds deal to expand healthcare data license
Jul 27, 2026 09:02AM DataMEDS AI updates record date for meme coin distribution to stockholders
Jul 27, 2026 09:00AM DataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders
Jul 22, 2026 08:15AM DataMEDS AI begins trading on Nasdaq under new ticker symbol MEDS
Jul 22, 2026 08:15AM DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets
May 28, 2025 07:54AM Wellgistics Health (WGRX) Announces Management Appointments
May 28, 2025 07:45AM Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value
Jan 21, 2025 08:16AM Oragenics (OGEN) Provides Shareholder Update on Strategic Progress and Announces Janet Huffman as Interim CEO
Sep 24, 2024 08:02AM TRxADE HEALTH (MEDS) Announces Name Change to Scienture Holdings, Ticker Change to "SCNX"
Jul 26, 2024 08:03AM TRxADE HEALTH (MEDS) Announces Business Combination with Scienture, Inc., in Transaction Valued at $103 Million
Jul 26, 2024 07:55AM TRxADE HEALTH (MEDS) Halted, News Pending
Jul 9, 2024 08:11AM TRxADE HEALTH (MEDS) Declares $1.50 Special Dividend; 9.7% Yield